C256-0435 Screening compound: 1-(5-bromo-6-{[4-(2-methylpiperidine-1-carbonyl)piperidin-1-yl]sulfonyl}-2,3-dihydro-1H-indol-1-yl)propan-1-one

C256-0435 Screening compound: 1-(5-bromo-6-{[4-(2-methylpiperidine-1-carbonyl)piperidin-1-yl]sulfonyl}-2,3-dihydro-1H-indol-1-yl)propan-1-one
C256-0435 Screening compound: 1-(5-bromo-6-{[4-(2-methylpiperidine-1-carbonyl)piperidin-1-yl]sulfonyl}-2,3-dihydro-1H-indol-1-yl)propan-1-one alternative view

Chemical Structure Depiction of ChemDiv screening compound C256-0435
1-(5-bromo-6-{[4-(2-methylpiperidine-1-carbonyl)piperidin-1-yl]sulfonyl}-2,3-dihydro-1H-indol-1-yl)propan-1-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C256-0435

Molecular Formula

C23H32BrN3O4S (C23 H32 BrN3 O4 S)

Compound Name

1-(5-bromo-6-{[4-(2-methylpiperidine-1-carbonyl)piperidin-1-yl]sulfonyl}-2,3-dihydro-1H-indol-1-yl)propan-1-one

IUPAC name

1-(5-bromo-6-{[4-(2-methylpiperidine-1-carbonyl)piperidin-1-yl]sulfonyl}-23-dihydro-1H-indol-1-yl)propan-1-one

SMILES

CCC(N(CCc1c2)c1cc(S(N(CC1)CCC1C(N1C(C)CCCC1)=O)(=O)=O)c2Br)=O

InChI

InChI=1S/C23H32BrN3O4S/c1-3-22(28)27-13-9-18-14-19(24)21(15-20(18)27)32(30,31)25-11-7-17(8-12-25)23(29)26-10-5-4-6-16(26)2/h14-17H,3-13H2,1-2H3/t16-/m0/s1

InChI Key

GVJIBUJHBKVADC-INIZCTEOSA-N

MDL Number (MFCD)

MFCD14736432

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

526.49

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.273

Distribution Coefficient, logD

3.273

Water Solubility, LogSw

-3.57

Polar Surface Area

63.306

Acid Dissociation Constant (pKa)

22.26

Base Dissociation Constant (pKb)

0.94

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

65.22

C256-0435 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with C256-0435 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C256-0435?
Check Price and Availability of C256-0435, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C256-0435 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C256-0435
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C256-0435
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C256-0435 available by request